Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries
-
Published:2020-06
Issue:
Volume:23
Page:100401
-
ISSN:2589-5370
-
Container-title:EClinicalMedicine
-
language:en
-
Short-container-title:EClinicalMedicine
Author:
Kjaer Susanne K., Nygård Mari, Sundström Karin, Dillner Joakim, Tryggvadottir Laufey, Munk Christian, Berger Sophie, Enerly Espen, Hortlund Maria, Ágústsson Ágúst Ingi, Bjelkenkrantz Kaj, Fridrich Katrin, Guðmundsdóttir Ingibjorg, Sørbye Sveinung Wergeland, Bautista Oliver, Group ThomasORCID, Luxembourg Alain, Marshall J. Brooke, Radley David, Yang Yi Shen, Badshah Cyrus, Saah Alfred
Reference39 articles.
1. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis;de Martel;Lancet Glob Health,2020 2. Worldwide burden of cancer attributable to HPV by site, country and HPV type;de Martel;Int J Cancer,2017 3. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide;Alemany;Int J Cancer,2015 4. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study;de Sanjose;Lancet Oncol,2010 5. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions;Serrano;Eur J Cancer,2015
Cited by
109 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|